Inactive Instrument
Hydropothecary Corp Share Price Toronto S.E.
Stocks
THCX
CA44903W1059
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
||
| - CAD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Carl Merton
CEO | Chief Executive Officer | 57 | 21/06/2023 |
Pamela McRae
CTO | Chief Tech/Sci/R&D Officer | - | - |
Richard Redekop
COO | Chief Operating Officer | - | 14/06/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Vincent Chiara
BRD | Director/Board Member | - | 03/11/2016 |
Peter Montour
BRD | Director/Board Member | - | 29/08/2021 |
William Montour
BRD | Director/Board Member | - | 04/01/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.15% | -2.67% | +219.71% | -6.81% | 2.48B | ||
| +4.52% | +1.97% | +116.40% | +102.07% | 1.69B | ||
| +0.22% | -2.49% | -24.97% | +123.25% | 452M | ||
| 0.00% | -4.92% | +16.00% | -3.33% | 63.21M | ||
| Average | +1.22% | -1.63% | +81.78% | +53.79% | 1.17B | |
| Weighted average by Cap. | +1.73% | -0.99% | +156.13% | +45.03% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- HEXO Stock
- THCX Stock
Select your edition
All financial news and data tailored to specific country editions
















